Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
No definition available.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Other and unspecified immunodeficiencies with predominantly antibody defects based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 203 | 133 | 70 |
Unadjusted prevalence (%) | 0.08 | 0.09 | 0.06 |
Mean age at first event (years) | 47.67 | 48.86 | 45.40 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.22 | 16.45 [6.62, 40.87] | 1.6e-9 | 17 |
15 years | 0.10 | 15.49 [6.19, 38.73] | 4.7e-9 | 16 |
5 years | 0.02 | 19.72 [7.81, 49.80] | 2.8e-10 | 11 |
1 year | - | - | - | - |
Index endpoint: D3_IMMUDEFANTIBODYNAS – Other and unspecified immunodeficiencies with predominantly antibody defects
GWS hits: 1
before Other and unspecified immunodeficiencies with predominantly antibody defects
after Other and unspecified immunodeficiencies with predominantly antibody defects
Loading survival analyses plot
Loading survival analyses table